Other languages Castle Biosciences, Inc.

Equities

CSTL

US14843C1053

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-03 pm EDT			5-day change	1st Jan Change
24.33 ^USD	+6.52%		+19.62%	+12.74%

May. 02	Transcript : Castle Biosciences, Inc., Q1 2024 Earnings Call, May 02, 2024
May. 02	Earnings Flash (CSTL) CASTLE BIOSCIENCES Posts Q1 Revenue $73M, vs. Street Est of $66.2M	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Castle Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 02
Castle Biosciences, Inc. Revises Earnings Guidance for the Full Year of 2024	May. 02
Castle Biosciences Insider Sold Shares Worth $441,853, According to a Recent SEC Filing	Apr. 08
Castle Biosciences, Inc. Announces Share New Data At the 20Th European Association of Dermato-Oncology Congress	Apr. 04
Castle Biosciences, Inc. Announces Board Changes	Mar. 27
Castle Biosciences, Inc. Announces the Publication of an Expert Consensus Article in the Journal of Clinical and Aesthetic Dermatology	Mar. 19
Castle Biosciences, Inc. Announces the Publication of a New Multi-Center Performance Study of its DecisionDx-SCC Risk Stratification Test	Mar. 07
Castle Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28
Castle Biosciences, Inc. Provides Revenue Guidance for the Full Year 2024	Feb. 28
Castle Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28
Castle Biosciences Insider Sold Shares Worth $493,818, According to a Recent SEC Filing	Feb. 07
Castle Biosciences, Inc. Presents Data Supporting the Utility of Its Tests in the Clinical Care of Patients with Skin Cancers at the 2024 Winter Clinical Dermatology Conference - Hawaii	Jan. 14
Castle Biosciences Insider Sold Shares Worth $475,585, According to a Recent SEC Filing	Jan. 08
Castle Biosciences Sees 53% Growth in Annual Revenue in 2023	Jan. 08
Castle Biosciences, Inc. Provides Revenue Guidance for the Year 2023	Jan. 07
Castle Biosciences Insider Sold Shares Worth $301,774, According to a Recent SEC Filing	Dec. 29
Castle Biosciences Insider Sold Shares Worth $260,466, According to a Recent SEC Filing	Dec. 27
Castle Biosciences Insider Sold Shares Worth $393,446, According to a Recent SEC Filing	Dec. 22
Castle Biosciences Insider Sold Shares Worth $334,542, According to a Recent SEC Filing	Dec. 21
Castle Biosciences Insider Sold Shares Worth $496,967, According to a Recent SEC Filing	Dec. 18

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Castle Biosciences, Inc.

Equities

CSTL

US14843C1053

Other languages

Filters